West Pharmaceutical Services, Inc.(WST)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Instruments & Supplies
West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Latest News & Analysis

West Pharmaceutical Services (WST) stock analysis: Securities law investigation and revised guidance impact investor decisions.
Apr 9, 2025

West Pharmaceutical Services (WST) Faces Scrutiny: What Investors Need to Know

West Pharmaceutical Services (WST) faces scrutiny over revised 2025 guidance and a securities law investigation, impacting investor confidence and stock performance.

Read more →
West Pharmaceutical Services investigation: Analysis of stock impact, fraud allegations, and dividend outlook.
Mar 25, 2025

West Pharmaceutical Services (WST): Securities Fraud Investigation Impact

West Pharmaceutical Services (WST) faces a securities fraud investigation after lowered 2025 guidance, impacting stock and investor confidence.

Read more →
West Pharmaceutical Services: Navigating investigation, GLP-1 market, and strategic outlook for investors.
Mar 19, 2025

West Pharmaceutical Services (WST): Investigation and Market Impact

West Pharmaceutical Services (WST) faces a securities fraud investigation amid lowered 2025 guidance. Despite challenges, long-term growth potential exists.

Read more →
West Pharmaceutical Services (WST) Analysis: GLP-1 Growth vs. Investigation Impact - Get the Investment Insights
Mar 17, 2025

West Pharma (WST): Securities Fraud Investigation & GLP-1 Growth

West Pharmaceutical Services (WST) faces a securities fraud investigation and lowered guidance, but opportunities in GLP-1 medications offer potential growth.

Read more →
West Pharmaceutical Services: Navigating challenges and GLP-1 opportunities. Stay informed on WST's stock analysis, market dynamics, and future growth potential.
Mar 13, 2025

West Pharmaceutical Services (WST): Securities Investigation, GLP-1 Growth

West Pharmaceutical Services (WST) faces a securities investigation amid lowered 2025 guidance, impacting investor sentiment. GLP-1 medication demand offers growth, but supply chain issues persist.

Read more →
West Pharmaceutical Services analysis: Navigating market challenges, GLP-1 opportunities, and investor considerations for WST.
Mar 11, 2025

West Pharmaceutical Services (WST): Investigation and Market Impact

West Pharmaceutical Services (WST) navigates a securities law investigation and lowered guidance amidst GLP-1 market growth. Investors should monitor key developments.

Read more →
West Pharmaceutical Services faces lowered guidance, securities investigation. Analysis of WST stock performance, financial outlook, and strategic response.
Mar 6, 2025

West Pharma (WST): Securities Investigation and Guidance Impact

Analysis of West Pharmaceutical Services (WST) amidst lowered guidance, a securities investigation, and declining profit margins. Key insights for investors.

Read more →
West Pharmaceutical Services stock analysis: Investigating uncertainty and strategic shifts in medical supplies.
Mar 3, 2025

West Pharmaceutical Services, Inc. News and Analysis

Analysis of West Pharmaceutical Services, Inc. (WST) amid securities fraud investigations and revised guidance. Dive into market reactions and future outlook.

Read more →
West Pharmaceutical Services: Navigating Lowered Guidance and Securities Probe. An analysis of WST's performance, challenges, and strategic outlook.
Feb 28, 2025

West Pharmaceutical Services: Navigating Uncertainty Amidst Investigation

West Pharmaceutical Services navigates uncertainty amid lowered guidance and a securities probe. Key is understanding Q4 results, industry trends, and analyst ratings.

Read more →
West Pharmaceutical Services (WST) stock analysis: Navigating revised guidance, securities probe, and market volatility. Insights for investors on Q4 results, 2025 outlook, and future prospects.
Feb 27, 2025

West Pharmaceutical Services (WST) Under Pressure: Guidance Revision

West Pharmaceutical Services faces scrutiny after revising its 2025 guidance downwards, triggering securities fraud investigations. Investors should remain cautious.

Read more →
West Pharma stock analysis: Dividend sustainability, market turbulence, and long-term prospects.
Feb 26, 2025

West Pharma's Dividend Under Pressure: Navigating Headwinds

West Pharmaceutical Services faces dividend pressure amidst market turbulence, securities fraud allegations, and lowered guidance. A detailed analysis of WST's challenges and prospects.

Read more →
Stock chart trending downwards against a backdrop of pharmaceutical manufacturing, symbolizing financial challenges in the pharmaceutical sector.
Feb 18, 2025

West Pharmaceutical Services: Stock Plunge Amid Weak 2025 Guidance

In-depth analysis of West Pharma's Q4 earnings and 2025 guidance, driven by currency headwinds, destocking trends, and strategic capacity expansion.

Read more →
Stock performance graph for West Pharmaceutical Services (WST) showing key events and pharmaceutical packaging elements.
Feb 14, 2025

West Pharmaceutical Services Navigates 2025 Challenges

Detailed analysis reveals robust Q4 earnings but 2025 guidance challenges from strong currency headwinds and client inventory reductions.

Read more →